Senate Bill 3356
115th Congress(2017-2018)
Synthetic Drug Awareness Act of 2018
Introduced
Introduced in Senate on Aug 21, 2018
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3356
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Synthetic Drug Awareness Act of 2018
This bill requires the Surgeon General to report to Congress on the health effects of new psychoactive substances (e.g., synthetic marijuana), specifically those used since January 2010 by individuals who are 12 to 18 years old.
August 21, 2018
Sort by most recent
08/21/2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
08/21/2018
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:41:41 PM